BRETEC — Bioretec Oy Cashflow Statement
0.000.00%
Last trade - 00:00- €4.22m
- €0.53m
- €3.52m
Annual cashflow statement for Bioretec Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.02 | -2.42 | -3.79 | -4.61 | -9.48 |
| Depreciation | |||||
| Non-Cash Items | 3.35 | 0.125 | 0.755 | 0.412 | 2.03 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.11 | -0.248 | -0.604 | -1.05 | -2.52 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.39 | -2.36 | -3.44 | -5.11 | -9.76 |
| Capital Expenditures | -0.393 | -0.26 | -0.161 | -0.729 | -0.584 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.393 | -0.26 | -0.161 | -0.729 | -0.584 |
| Financing Cash Flow Items | -1.79 | -1.51 | -0.775 | -0.531 | -1.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.13 | -2.78 | 9.29 | 5.21 | 8.18 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.35 | -5.4 | 5.69 | -0.621 | -2.16 |